Annual report [Section 13 and 15(d), not S-K Item 405]

SCHEDULE OF STOCK OPTIONS ACTIVITY (Details)

v3.26.1
SCHEDULE OF STOCK OPTIONS ACTIVITY (Details) - USD ($)
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Equity [Abstract]    
Number of Shares, Outstanding, beginning balance 796,660 1,605,060
Weighted Average Exercise Price, Outstanding, beginning balance $ 4.10 $ 4.85
Number of Shares, Granted 536,239
Number of Shares, Exercised (62,125)
Number of Shares, Forfeited and cancelled (341,892) (808,400)
Weighted Average Exercise Price, Forfeited and cancelled $ 3.43 $ 5.60
Weighted Average Grant Date Fair Value, beginning balance 3.08  
Weighted Average Exercise Price, Granted 1.88  
Weighted Average Grant Date Fair Value, Granted 1.23  
Weighted Average Exercise Price, Exercised 4.10  
Weighted Average Grant Date Fair Value, Exercised $ 3.40  
Aggregate intrinsic Value, Exercised $ 115,095  
Weighted Average Grant Date Fair Value, Forfeited and cancelled $ 2.53  
Number of Shares, Outstanding, ending balance 928,882 796,660
Weighted Average Exercise Price, Outstanding, ending balance $ 3.06 $ 4.10
Weighted Average Remaining Contract Term (years), Outstanding 7 years 9 months  
Weighted Average Grant Date Fair Value, ending balance $ 2.20 $ 3.08
Number of Shares, Exercisable, ending balance 368,997  
Weighted Average Exercise Price, Exercisable, ending balance $ 4.18  
Weighted Average Remaining Contract Term (years), exercisable 6 years 6 months 10 days  
Weighted Average Grant Date Fair Value, Exercisable $ 3.14